RC

Rodolphe Clerval

Chief Executive Officer

Coave Therapeutics

Paris, Ile-de-France


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Coave Therapeutics
Industry
research
Employees
42.0
Seniority
C suite
Total Funding
89305285.0
Latest Funding
Series A

Technologies

Outlook Microsoft Office 365 Typekit WordPress.org Google Tag Manager Vimeo Mobile Friendly Apache Google Font API Viewpoint AI

Keywords

medecine therapie genique ophtalmologie gene therapy rare ocular disease cns disease biotechnology research aligater platform ocular diseases neurodegenerative diseases targeted delivery genetic medicine aav vectors lnp vectors biologics clinical trials suprachoroidal administration retinitis pigmentosa cns diseases aav-ligand conjugates bioconjugation manufacturing processes safety profile efficacy transgene delivery biodistribution gene replacement therapy therapeutic candidates pathogenic pathways clinical development early-stage biotechnology gene therapy manufacturing advanced genetic medicines rare diseases therapeutic strategies autophagy-lysosomal pathway protein aggregation biotechnology collaborations research partnerships investigational new drug cns-targeted therapies targeted gene therapy novel gene delivery systems biotechnology innovation medical advancements ocular gene therapy genetic constructs disease-modifying therapies high-capacity manufacturing clinical applications translational research gene therapy regulations therapeutic targets disease treatment strategies health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans